
Daojing Wang is the founder, president, and CEO of Newomics, a Berkeley biotech building chip-based mass spectrometry tools for precision medicine. A Princeton-trained chemist who spent 11 years as a principal investigator at Lawrence Berkeley National Laboratory, he co-invented the M3 emitter and multinozzle emitter array (MEA) - a silicon shower-head that makes mass spectrometers far more sensitive. He spun the technology out of the national lab in 2013 and has since shipped well over 100 systems to labs worldwide.
Newomics is a Berkeley, California biotechnology company building mass spectrometry front-end hardware for precision medicine. Spun out of Lawrence Berkeley National Laboratory, its silicon multinozzle emitter (M3) and MnESI ion source upgrade existing mass spectrometers to deliver microflow robustness with nanospray sensitivity, enabling higher-throughput, higher-sensitivity multiomics across proteomics, metabolomics, lipidomics, native MS and single-cell analysis. The company sells to pharmaceutical, academic and government labs and co-markets with major instrument vendors like Thermo Fisher Scientific.